Hyrnuo

Active Ingredient(s): Sevabertinib
FDA Approved: * November 19, 2025
Pharm Company: * BAYER HEALTHCARE
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Hyrnuo 10 mg Oral Tablet, Film Coated
NDC: 50419-397
Labeler:
Bayer Healthcare Pharmaceuticals Inc.